Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway

被引:10
|
作者
Chavakis, E
Dernbach, E
Hermann, C
Mondorf, UF
Zeiher, AM
Dimmeler, S
机构
[1] Univ Frankfurt, Dept Internal Med 4, Div Mol Cardiol, D-60590 Frankfurt, Germany
[2] Univ Frankfurt, Dept Internal Med 4, Div Nephrol, D-60590 Frankfurt, Germany
关键词
endothelium; lipoproteins; growth substances;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Oxidized LBL (oxLDL) inhibits endothelial cell (EC) migration. Stimulating ECs with vascular endothelial growth factor (VEGF) leads to the activation of Akt/protein kinase B, which in turn activates endothelial nitric oxide synthase (eNOS) by phosphorylation on serine 1177. VEGF-induced cell migration is dependent on the generation of nitric oxide (NO). Therefore, we investigated whether oxLDL affects EC migration by an inhibitory effect on the Akt/eNOS pathway. Methods and Results-During an in vitro "scratched wound assay," oxLDL, dose-dependently inhibited the VEGF-induced migration of human umbilical vein endothelial cells, Western blot analysis revealed that oxLDL dose- and time-dependently led to dephosphorylation and thus deactivation of Akt. Moreover, oxLDL inhibited the VEGF-induced generation of NO, as detected and quantified using a fluorescent NO indicator, 4,5-diaminofluorescein diacetate. Overexpression of a constitutively active Akt construct (Akt T308D/S473D) or a phosphomimetic eNOS construct (eNOS S1177D) almost completely reversed the inhibitory effect of oxLDL on VEGF-induced EC migration and NO generation. Conclusions-Our data indicate that oxLDL-induced dephosphorylation of Akt, followed by impaired eNOS activation: reduces the intracellular level of NO and thereby inhibits VEGF-induced EC migration.
引用
收藏
页码:2102 / 2107
页数:6
相关论文
共 50 条
  • [41] Autotaxin Signaling via Lysophosphatidic Acid Receptors Contributes to Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration
    Ptaszynska, Malgorzata M.
    Pendrak, Michael L.
    Stracke, Mary L.
    Roberts, David D.
    MOLECULAR CANCER RESEARCH, 2010, 8 (03) : 309 - 321
  • [42] Redox Regulation of SERCA2 Is Required for Vascular Endothelial Growth Factor-Induced Signaling and Endothelial Cell Migration
    Evangelista, Alicia M.
    Thompson, Melissa D.
    Weisbrod, Robert M.
    Pimental, David R.
    Tong, XiaoYong
    Bolotina, Victoria M.
    Cohen, Richard A.
    ANTIOXIDANTS & REDOX SIGNALING, 2012, 17 (08) : 1099 - 1108
  • [43] A role of receptor protein tyrosine phosphatase beta/zeta in vascular endothelial growth factor-induced endothelial cell migration
    Koutsioumpa, Marina
    Poimenidi, Evangelia
    Theodoropoulou, Christina
    Pantazaka, Evangelia
    Skoura, Angeliki
    Megalooikonomou, Vasileios
    Kieffer, Nelly
    Courty, Jose
    Sugahara, Kazuyuki
    Papadimitriou, Evangelia
    ANGIOGENESIS, 2014, 17 (03) : 754 - 754
  • [44] Vascular endothelial growth factor-induced endothelial cell migration and proliferation depends upon an NO-mediated decrease in PKC δ.
    Shizukuda, Y
    Tang, SQ
    Ware, JA
    CIRCULATION, 1998, 98 (17) : 39 - 39
  • [45] Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity
    Mahmoud Refaie, Marwa Monier
    Bayoumi, Asmaa M. A.
    Mokhemer, Sahar Ahmed
    Shehata, Sayed
    Abd El-Hameed, Nahla Mohammed
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
  • [46] Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity
    Refaie, Marwa Monier Mahmoud
    Bayoumi, Asmaa M. A.
    Mokhemer, Sahar Ahmed
    Shehata, Sayed
    El-Hameed, Nahla Mohammed Abd
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
  • [47] BIOCHANIN A INHIBITS VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED ANGIOGENESIS OF HUMAN UMBILICAL VASCULAR ENDOTHELIAL CELLS THROUGH REGULATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE AND SERINE/THREONINE PROTEIN KINASE-AKT
    Wang, Shuaiyu
    Sung, Mi-Jeong
    Hwang, Jin-Taek
    Hur, Haeng-Jeon
    Kim, Hyun-Jin
    Yang, Hye Jeong
    Kim, Myung-Sunny
    Kwon, Dae Young
    Park, Jae-Ho
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2011, 9 (03) : 99 - 104
  • [48] The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel taxotere)
    Lu, HY
    Murtagh, J
    Schwartz, EL
    MOLECULAR PHARMACOLOGY, 2006, 69 (04) : 1207 - 1215
  • [49] Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension
    Eechoute, K.
    van der Veldt, A. A. M.
    Oosting, S.
    Kappers, M. H. W.
    Wessels, J. A. M.
    Gelderblom, H.
    Guchelaar, H-J
    Reyners, A. K. L.
    van Herpen, C. M. L.
    Haanen, J. B.
    Mathijssen, R. H. J.
    Boven, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 503 - 510
  • [50] Mechanisms of Vascular Endothelial Growth Factor-Induced Pathfinding by Endothelial Sprouts in Biomaterials
    Shamloo, Amir
    Xu, Hui
    Heilshorn, Sarah
    TISSUE ENGINEERING PART A, 2012, 18 (3-4) : 320 - 330